Unknown: Rituxan (rituximab) has been assigned to pregnancy category c by the fda. Animal studies have not been conducted. There are no controlled data in human pregnancy. There are no data on whether Rituxan (rituximab) can cause fetal harm when administered to a pregnant woman. . Postmarketing data indicate that b-cell lymphocytopenia generally lasting less than six months can occur in infants exposed to Rituxan (rituximab) in utero.
Answered 7/1/2014
5.7k views
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question